EGFR and breast carcinoma: Our previous study have shown that EGFR promotes breast cancer invasion through downstream p44/p42 MAPK (ERK1/2) signaling [11], and resistin is known to enhance angiogenesis in human osteosarcoma cells via the ERK1/2 signaling [12].